Morning Market Movers

Cubist Pharmaceuticals CBST shares climbed 35.66% to $100.88 after Merck MRK announced its plans to acquire Cubist for $102 per share in cash. BioLineRx BLRX shares jumped 17.47% to $1.74 after the company reported positive data from ongoing Phase 2a Study for AML treatment. Louisiana-Pacific LPX shares gained 9.85% to $17.03. Louisiana-Pacific shares have dropped 3.85% over the past 52 weeks, while the S&P 500 index has gained 14.76% in the same period. Acceleron Pharma XLRN rose 7.56% to $40.40. Celgene CELG and Acceleron announced new data from Luspatercept Phase 2 clinical trial in beta-thalassemia. Agios Pharmaceuticals AGIO shares surged 3.42% to $109.65 after the company reported Celgene decision to extend discovery phase of global strategic collaboration to April 2016. The company also announced positive data from ongoing Phase 1 trial of AG-221 at ASH Annual Meeting. Randgold Resources GOLD shares jumped 2.76% to $66.64 after falling 2.26% on Friday. Celgene CELG shares climbed 2.42% to $116.89 after the company and Acceleron Pharma XLRN announced new data from Luspatercept Phase 2 clinical trial in beta-thalassemia. The Nasdaq OMX Group NDAQ rose 1.53% to $46.38 after analysts at Keefe Bruyette & Woods upgraded the stock from Market Perform to Outperform and raised the price target from $45 to $55.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversForest Productsmarket moversMaterialsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!